HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.
暂无分享,去创建一个
[1] M. Jauffret-Roustide,et al. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey. , 2016, Revue d'epidemiologie et de sante publique.
[2] D. D. Des Jarlais,et al. HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks. , 2016, AIDS.
[3] M. Carrieri,et al. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study. , 2016, Addiction.
[4] F. Serre,et al. Change in HIV-HCV Risk-Taking Behavior and Seroprevalence Among Opiate Users Seeking Treatment Over an 11-year Period and Harm Reduction Policy , 2012, AIDS and Behavior.
[5] J. Desenclos,et al. Population-based HIV-1 incidence in France, 2003-08: a modelling analysis. , 2010, The Lancet. Infectious diseases.
[6] J. Desenclos,et al. A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design , 2009, BMC infectious diseases.
[7] F. Ingold,et al. [Attitudes and practices of drug users confronted with the risks of contamination by human immunodeficiency virus (HIV) and hepatitis B and C viruses]. , 1997, Bulletin de l'Académie Nationale de Médecine.